ThermoGenesis

ThermoGenesis Holdings, Inc. is a pioneer and market leader in the development and commercialization of automated cell processing technologies for the cell and gene therapy fields. ThermoGenesis Corp., a subsidiary of ThermoGenesis Holdings, Inc., provides a full range of solutions for the emerging CAR-T immunotherapy market, used for automating clinical biobanking, point-of-care applications, and large-scale cell processing and manufacturing. For over two decades, ThermoGenesis Holdings, Inc. has developed and commercialized innovative cell processing systems and devices, offering efficient cell processing equipment to researchers, biomanufacturing organizations, and clinicians worldwide, helping them achieve better outcomes across various applications in cell and gene therapy.